Retatrutide is a new pharmaceutical in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By boosting these receptors, https://ezekielcsrz739424.jts-blog.com/35065947/tirzepatide-a-promising-new-treatment-for-obesity